Peter M. Grace

Peter M. Grace, Ph.D., is an Associate Professor and interim Department Chair in the Department of Symptom Research at The University of Texas MD Anderson Cancer Center. His research focuses on neuroimmune mechanisms underlying chronic pain, particularly neuropathic pain and opioid pharmacology. He investigates pathways such as Nrf2 antioxidant signaling, inflammasome activation, and immune-mediated pain modulation. His work bridges basic science and translational research, aiming to develop therapies targeting oxidative stress and neuroinflammation.

Key research interests include the role of B cells and IgG in neuropathic pain, the impact of opioids on pain amplification, and the protective effects of exercise on nerve injury outcomes. He explores novel therapies like fumarates and HDAC inhibitors to mitigate pain and neurodegeneration. Grace’s interdisciplinary approach integrates immunology, neuroscience, and clinical pain management.

His publications highlight advancements in understanding microglial activity in pain-related brain regions, TLR4 signaling in morphine tolerance, and the development of targeted drug delivery systems for oxidative stress disorders. Despite his extensive contributions, specific awards are not listed in the provided materials.